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Abstract - Biosensors based on immobilized microbial cells were developed for drug screening in our 
laboratory. Compared with the conventional methods such as diffusion and dilution tests, biosensors 
have been demonstrated to be superior in sensitivity and require much shorter screening time. An 
integrated microcomputer system has been developed for data acquisition, database management, 
and mode of action estimation, which automates the screening processes and reduces the labor 
requirements significantly. 
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INTRODUCTION 
In search for anti-tumor and anti-microbial drugs, a great deal of effort has been spent in 
biological testing and screening. Conventional testing and screening methods, such as 
diffusion and dilution tests Cl], are labor-intensive in both the testing procedures and 
subsequent data analyses. Biosensors have been suggested as a promising alternative for 
biological testing [2-41. 
In our laboratory, biosensors with immobilized mammalian and microbial cells were 
developed to test the activities of anti-tumor and anti-microbial drugs [5,6]. The biosensor 
is consisted of two parts. One is the disposable immobilized cellular disk. The other is a 
dissolved oxygen (D.O.) electrode. The mammalian cells and microbial cells used in testing 
were immobilized in various matrices such as a filter paper disk coupled to the electrode as 
shown in Fig. 1. These cellular disks can be attached to the tip of the D.O. electrode just prior 
to testing. The biosensor assembly can then be put in a temperature controlled vessel 
containing drug and culture medium for testing. Filtered sterile air is bubbled through the 
medium to supply oxygen for the cells. The interaction between the cells and the drug can be 
detected indirectly by monitoring the oxygen uptake of the cells. When the cells grow, more 
oxygen will be consumed and less oxygen will diffuse into the D.O. electrode. When the cells 
are inhibited or killed by the drug, more oxygen can diffuse through the cellular disk and 
reach the electrode surface, resulting in a higher current output of the electrode when 
compared to the control. Unlike the diffusion and dilution tests which provide only end 
points results, biosensor response curves reveal drug and cell interaction during the entire 
testing period. The response curve patterns of the biosensors can be used to evaluate various 
drugs as demonstrated by our experimental results. 
In order to reduce the labor intensive effort required in testing and data analyses, we have 
developed in our laboratories an integrated microcomputer system for data acquisition, data 
processing, database management, and mode of action estimation. The biosensor output can 
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Fig. 1. Schematic diagram of biosensor 
be stored in a pre-formatted database without off-line processing. These records can be 
retrieved from the database using several key words and then compared with old and new 
records in tabulated or graphical forms. A prototype expert system was also developed for 
consultation support to evaluate various drugs and chemicals. 
EXPERIMENTAL RESULTS 
Immobilized E. co/i and yeast cell disks were used in our initial experimental models. 
Various antibiotics (or drugs) with well known modes of action, such as ampicillin, 
tetracycline, nystatin, and cychloheximide were employed as model drugs for comparison 
and demonstration purposes! The experimental setup and procedures are essentially the 
same as those described in earlier published results from this laboratory [5,6]. 
Some typical response curves of the biosensors are displayed in Figs 2-5. Figure 2 shows 
the response curves of the biosensor with immobilized E. coli cells at different ampicillin 
concentrations. The initial cell concentration in the cellular disks is around 3.3 x IO’ 
cells/ml. When the drug concentrations greater than lOpg/ml are used, the current output of 
the biosensor shows a similar pattern, e.g. the biosensor current output gradually decrease 
initially, and then gradually increase afterward. This pattern can be related to the mode of 
action of ampicillin on E. coli. Ampicillin is a drug which inhibits the cell wall synthesis of E. 
coli [7] thus causing cell wall leakage. A reduction of the current output during the first part 
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of the curve correlates to initial cell growth (and therefore more oxygen uptake). The rise 
during the second part of the curve suggests the growing cells lose their viability (and 
therefore less oxygen uptake) as the drug exerts its action on the growing cells and causes 
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Fig. 2. Effect of different concentrations of ampicillin on the E. coli biosensor current output. Initial 
cell concentration = 3.3 x 10’ cell/ml, tested in growth medium, temperature = 3O”C, current output 
of biosensor with dead cells = 13pA. 
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Fig. 3. Effect of different concentrations of tetracycline on theE. coli biosensor current output. Initial 
cell concentration = 3.3 x lO’cell/ml, tested in growth medium, temperature = 3O”C, current output 
of biosensor with dead cells = 13~A. 
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Fig. 4. Effect of different concentrations of nystatin on the yeast biosensor current output. Initial cell 
concentration = 2.7 x 10’ cell/ml, tested in growth medium, temperature = 30°C current output of 
biosensor with dead cells = 13pA. 
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Fig. 5. Effect of different concentrations of cycloheximide on the yeast biosensor current output. 
Initial cell concentration = 2.7 x 108 cell/ml, tested in growth medium, temperature = 3O”C, current 
output of biosensor with dead cells = 13pA. 
serious damage to the cells. At a drug concentration of 1 pg/ml, the response curve is similar to 
the control (0 pg/ml). This indicates that the minimum inhibitory concentration (MIC) is 
between 1 and 10 pg/ml, which agrees with previous published results (8 pg/ml) [7]. More 
exact MIC concentration can be determined using narrower ampicillin concentrations. 
Figure 3 shows the effect of different concentrations of tetracycline on the output of biosensor 
with immobilized E. co/i cells. Tetracycline inhibits protein synthesis of bacterial cells [8], 
and can be shown to cause a complete different current output pattern of the biosensor with 
immobilized E. coli when compared to ampicillin. The current output remains nearly 
unchanged when the drug concentration is greater than 4.6 pg/ml, suggesting the E. coli is 
growth inhibited. The MIC of tetracycline should be between 4.6 and 0.9 pg/ml as indicated 
from Fig. 3, which is in agreement with the previous MIC data (4 pg/ml) in the literature [7]. 
Figures 5 and 6 show the effects of different concentrations of nystatin and cycloheximide 
on the output of biosensors using immobilized yeast cells. The initial cell concentration in the 
cell disks is 2.7 x 10’ cells/ml. The mode of action of nystatin is on membrane function, and 
cycloheximide is on protein synthesis [8]. Again, drugs with different modes of actions show 
different effects on the biosensor output. By using multiple cellular disks with different cells, 
an efficient screening test can thus be developed. 
Based on these experimental results, we demonstrated the feasibility of using biosensors 
for testing the activity of various drugs such as susceptibility of various microbial cells to 
antimicrobial agents in a relatively short period of time (2-5 hr.). The correlation between the 
response patterns of the biosensor and the mode of action of the drugs also demonstrates the 
possibility of using a pattern recognition technique to partially explain the mode of action of 
various drugs and chemicals based on the electrode response curves. Furthermore, 
biosensors show significant advantages in sensitivity when compared to conventional 
methods [l], which often required more then one day to complete the testing. Using 
appropriate initial cell concentrations (1 x 10’ to 1 x 10’ cells/ml), the change of cellular 
oxygen uptake caused by various immobilized procaryotic and eucaryotic cells can be 
detected continuously. Another advantage worth noting is the biosensor output, which is an 
electrical signal, can be readily processed using a computer automatically. 
Using biosensors to screen potential antimicrobial/antitumor agents can reduce the time 
required for each assay, however it cannot reduce the number of assays in a screening 
program. Comparison of many different assay results is needed to elucidate a meaningful 
conclusion. When large numbers of assays are carried gut, searching and comparing data in 
various forms becomes very labor intensive. Manual data reduction, book keeping and 
plotting work will significantly slow down the screening program. Automation of data 
collection, book keeping, and data analysis becomes an important requirement for a large 
scale biological testing and screening program. 
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In the last few years, the capacity and speed of microcomputers have increased several fold 
and the price/performance ratio has dropped significantly. Development of an integrated 
microcomputer system which includes the functions of automatic data acquisition, database 
management, and expert system for consultation support, becomes very beneficial for using 
biosensor in large scale screening and testing. The developed biosensor based integrated 
microcomputer system addresses these concerns. 
GENERAL FEATURE OF THE SYSTEM HARDWARE AND 
SOFTWARE 
An integrated microcomputer system for biosensing was developed recently in our 
laboratory. The hardware and software of this system are displayed schematically in Fig. 6. 
We chose a COMPAQ portable II model 4 microcomputer (COMPAQ Computer 
Corporation, Houston, Texas) with 8-MHZ 80286 CPU, 640 KB RAM, 20 MB HARD 
DRIVE, 360 KB FLOPPY DRIVE, as our basic unit. This system can be adapted to any IBM 
PC XT or AT, or compatible microcomputer with 5 12 KB RAM and a hard disk drive. The 
data acquisition unit consists of a DASCON-1 multifunction analog/digital I/O expansion 
board and a STA-01 screw termination board (MetraByte Corporation, Stoughton, 
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Fig. 6. Computer software and hardware of the system. 
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The software we developed is comprised of three parts. These are data acquisition, 
database management, and expert system, as shown in Fig. 6. The interface and the data 
acquisition parts are written in QuickBASIC (Microsoft Corporation, Redmond, 
Washington). QuickBASIC is an extension of the compiled BASIC language. It supports 
structure and modular programing. The I/O driver routine for DASCON-1, a machine 
language routine provided by MetraByte, can be placed in a user library and called from 
QuickBASIC for data acquisition. The SHELL statement supported by QuickBASIC 
enables us to execute other parts of the programs written in different languages from the 
interface. Disk files are used for communication between different parts of the program 
written in different languages. The database management program is written in Turbo 
PASCAL (Borland International, Inc., Scotts Valley, CA) for the numerous data structures 
supported by this language. Some of the procedures in the Turbo Database Toolbox 
(Borland International, Inc., Scotts Valley, CA) are employed in the database management 
part of the program. The expert system is written in Turbo Prolog (Borland International, 
Inc., Scotts Valley, CA). Turbo Prolog is an object-oriented language for application that 
involves formal or symbolic reasoning [9]. With Prolog, the user defines a goal or an 
objective, and the computer can find both the procedure and the solution based on the facts 
and the relationships among these facts encoded in the program. The compiled Turbo Prolog 
programs execute faster than any other Prolog programs on the market for the IBM PC and 
compatible computers [9]. Based on our experience, Turbo Prolog is a good language for 
developing small and mid-size expert systems for microcomputer. 
The software for biosensing is a menu-driven user-friendly program. All the functions can 
be chosen from menus and can be executed in an interactive way. Instructions and warnings 
are provided wherever they are necessary. People do not need any knowledge in 
programming to use this software. More details of the software will be presented in the 
following sections. 
DATA ACQUISITION 
The data acquisition module of the software provides all the functions needed for data 
acquisition and data processing. The following functions can be selected from the main menu: 
(1) data acquisition; (2) plot data; (3) take more data; (4) read old data from disk file; (5) data 
processing; (6) database management; (7) expert system; (8) quit. The data acquisition starts 
by asking the user to enter the time interval between data points and the total sampling time 
for reading the output of the biosensors into the computer memory. The time interval and 
total sampling time can be changed at any time during data acquisition. Whenever data are 
read from the biosensor, they are also displayed on the screen and stored in a disk file. During 
data acquisition, pressing function key Fl can display an interrupt menu on the screen. 
Several functions can be chosen from this menu. These functions are: (1) change time interval, 
total sampling time, and continue data logging; (2) stop taking data and go back to main 
menu; (3) plot previous data; (4) continue data logging; (5) clear previous data and start again. 
When the total sampling time is reached, the data logging will stop and the main menu will 
reappear on the screen. All the functions in the main menu can be selected repeatedly by the 
user. If the “plot data” function is selected, the biosensor response curve will be plotted on the 
screen. If the “take more data” function is selected, the data acquisition will continue 
according to the new time interval and the new total sampling time entered by the user. When 
the “data processing” function is selected, a data processing menu will appear on the screen. 
The following functions can be selected from this menu: (1) plot data; (2) select new time 
range; (3) find maximum gradient of the response curve, and the maximum and minimum 
current output. The function of selecting new time range enables one to choose the data in 
a specified time range to be stored in the database, and discards the rest of the data. The data 
at the beginning of new time range specified will be shifted to time zero and the time frame 
of the rest of the data will also be shifted accordingly. After the data acquisition and data 
processing, the data can be stored in the database using the function of database 
management. If the data has more than fifty points, the data will be interpolated into fifty 
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points and stored in a data buffer. These data points will later be read into the database by 
the database management program. 
DATABASE MANAGEMENT 
The database management module is developed specifically for managing the data 
acquired in bioscreening. Three main functions can be selected from the main menu of the 
database management module for book keeping and data comparison. They are: (1) add data 
records; (2) list data records; (3) find data records. 
The data structure of each data record is displayed in Fig. 7. The basic data records consist 
of 12 elements. They are: (1) record number; (2) entry date; (3) type of sensor; (4) cell line; (5) 
chemical (drug); (6) mode of action; (7) curve shape; (8) data file name for the response curve 
data; (9) cell concentration; (10) chemical concentration; (11) testing temperature; 
(12) remarks. All the elements, except record number and data file name for the response 
curve data, are entered by the user. A unique record number and a unique data file name for 
the response curve data are generated by the database management program. The data of the 
response curve, including time and current output, are transferred automatically from the 







Sorting and Searching Algorithm 
Fig. 7. Data structure of the biosensor database. 
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and added to the database. The data file name is the link between each data record and its 
response curve data. Since each data record has a length of 405 bytes, sorting and searching 
the specific elements in the data records will be slow. In order to reduce the sorting and 
searching time, five record elements, e.g. type of sensor, cell line, chemical, mode of action, 
and curve shape, are treated as key element, and put into five key files. Each key file contains 
one of the key elements for all the records. These key files with a B-tree structure can be sorted 
and searched efficiently [lo, 11). Any combination of these keys (from one to five) can be 
selected as the key words to search all the data records in the database which have the key 
elements that can match these keys. 
Two functions of the database management module can be used to retrieve the data records. 
The first is “List”. By using this function, the data records can be listed one by one, sorted by 
one of the key elements specified by the user. These data records and the response curves can 
be outputed either to the computer screen or to the printer. The other function for retrieving 
the data records is “Find”. After the user chooses this function, the computer provides the 
prompts for entering the key words and then individually displays the data records which 
match these key words. When the data record is displayed on the computer screen in the 
tabulated form, a select option window is also displayed on the bottom of the screen. The 
options in the select window include: (1) print record on printer; (2) plot response curve on 
screen; (3) select record as basic or compared record for comparison; (4) plot the response 
curve of the current record with any other response curve; (5) edit the record; (6) delete the 
record. 
With this database management module, any data record can be retrieved and compared 
with each other in tabulated and graphical forms using a few key strokes. 
EXPERT SYSTEM 
The purpose of the prototype expert system we developed is to help people evaluate and 
prescreen various drugs and chemicals. It has two functions: (1) consultation for mode of 
action of a drug; (2) consultation for response curve pattern recognition. The consultation for 
the mode of action of a drug is based on a knowledge base encoded in the expert system which 
includes more than two hundred drugs with known mode of actions acquired from literature 
[12, 131. The consultation for response curve pattern recognition is based on a knowledge 
base representing the correlations between the response curve patterns and the modes of 
actions of the drugs we obtained from various experiments. Figures 2-5 showed some of the 
examples of the biosensor response curves for various antibiotics having different modes of 
actions against different kind of cells. These response curve patterns can be related to the 
mode of action qualitatively. For example, the E. coli biosensor response curves for 
ampicillin are V shaped which can be related to the possible cell wall synthesis inhibition, 
while the E. coli biosensor response curves for tetracycline are nearly a straight line which can 
be related to possible protein synthesis inhibition. In the case where the drug concentration 
is higher than the minimum inhibition concentration (MIC), the response curves of a specific 
biosensor may have similar response patterns. However, please keep in mind that now only 
the mode of action of the drug, but also other factors, such as the concentration and the 
diffusivity of the drug, may also affect the shape of the response curves. Thus, this correlation 
between the drug mechanism and the response curve pattern can only be a qualitative one. 
We cannot “calculate” the mode of action based on the response curve. Instead, we try to 
simulate the human reasoning processes in this expert system to evaluate the mode of action 
of various drugs based on comparison of the acquired response curve pattern with the 
patterns of those drugs with well known modes of actions. These response curve patterns can 
be encoded in the expert system as rules and facts. During consultation, the user tells the 
expert system how the response curve obtained looks like by answering the questions that are 
raised by the expert system. Then the program will search the knowledge base to find the 
“match”. If one or more matches are found, the program can tell the user the possible (not 
exclusive) modes of actions of the drug. 
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SUMMARY 
Experimental results presented in this paper and the previous paper [S, 61 demonstrate 
that biosensors using detachable cellular disks are promising devices for antimicrobial/ 
antitumor screening. They showed higher sensitivity and require much shorter assay time 
compared to the dilution and diffusion tests. Unlike the conventional methods which provide 
only end point results, biosensors reveal continuous chemical and cell interaction during the 
entire screening period. Our experimental results also demonstrated interesting correlations 
between the response curve patterns and the modes of actions for various drugs. In order to 
effectively utilize the significant amount of information generated during screening, an 
integrated microcomputer system has been developed for data acquisition, database 
management, and mode of action estimation. The biosensor output can be stored in a 
pre-formatted database without off-line processing. The data records can be retrieved from 
the database using several key words and these records can be displayed and compared in 
either tabulated or graphical forms for evaluation. In conjunction with this system, a 
prototype expert system was developed for consultation support to evaluate various drugs 
or chemicals. The integrated microcomputer system provides a powerful tool for using 
biosensors in biological testing and screening. This system significantly reduced the labor 
requirements for data acquisition, data processing, and data management. It automated the 
biosensing processes and reduced the possible human errors in these processes. 
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